These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3735704)

  • 1. Phase II study of mitoxantrone in patients with non-small cell lung cancer.
    Suga J; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Sakurai M; Sano T; Tamura T; Hoshi A
    Jpn J Clin Oncol; 1986 Jun; 16(2):147-51. PubMed ID: 3735704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck.
    Mattox DE; Clark GM; Balcerzak SP; O'Bryan RM; Oishi N; Stuckey WJ
    Invest New Drugs; 1984; 2(4):405-7. PubMed ID: 6511243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
    Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer.
    Osborne CK; Drelichman A; Von Hoff DD; Crawford ED
    Cancer Treat Rep; 1983 Dec; 67(12):1133-5. PubMed ID: 6652630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
    De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II studies of mitoxantrone in patients with primary liver cancer.
    Falkson G; Coetzer BJ
    Invest New Drugs; 1985; 3(2):187-9. PubMed ID: 4019121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II clinical evaluation of dihydroxyanthracenedione in patients with advanced lung cancer.
    Valdivieso M; Umsawasdi T; Spitzer G; Chiuten DF; Booser DJ; Dhingra HM; Bodey GP
    Am J Clin Oncol; 1984 Jun; 7(3):241-4. PubMed ID: 6328968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of mitoxantrone].
    Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone in advanced bladder carcinoma. A phase II study of the EORTC Genito-urinary Tract Cancer Cooperative Group.
    van Oosterom AT; Fosså SD; Mulder JH; Calciati A; de Pauw M; Sylvester R
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1013-4. PubMed ID: 4065174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino 9,10-anthracenedione dihydrochloride)(NSC 301739, DHAD) in patients with metastatic malignant melanoma. A Southwest Oncology Group pilot.
    Taylor SA; Tranum BT; Von Hoff DD; Costanzi JJ
    Invest New Drugs; 1985; 3(1):67-9. PubMed ID: 3988458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of mitoxantrone on a daily X 5 schedule.
    Goldsmith MA; Ohnuma T; Jaffrey IH; Greenspan EM; Holland JF
    Am J Clin Oncol; 1984 Oct; 7(5):567-70. PubMed ID: 6507380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology Group.
    Knight WA; Von Hoff DD; Neidhart JA; Tranum BL; Fabian C; Jones SE
    Invest New Drugs; 1983; 1(2):181-4. PubMed ID: 6678866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group.
    Muss HB; Asbury R; Bundy B; Ehrlich CE; Graham J
    Am J Clin Oncol; 1984 Dec; 7(6):737-9. PubMed ID: 6528868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with upper gastrointestinal tumors. A preliminary report.
    Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey GP
    Am J Clin Oncol; 1983 Aug; 6(4):473-6. PubMed ID: 6869318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of mitoxantrone.
    Anderson KC; Cohen GI; Garnick MB
    Cancer Treat Rep; 1982 Nov; 66(11):1929-31. PubMed ID: 7139638
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of mitoxantrone in multiple myeloma: a Southwest Oncology Group Study.
    Alberts DS; Balcerzak SP; Bonnet JD; Stephens RL
    Cancer Treat Rep; 1985 Nov; 69(11):1321-3. PubMed ID: 4092195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of mitoxantrone in head and neck cancer.
    Aapro MS; Alberts DS
    Invest New Drugs; 1984; 2(3):329-30. PubMed ID: 6511239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study of mitoxantrone in advanced breast cancer].
    Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
    Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.